Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Daiichi Sankyo
Chinese Patent Office
Cerilliant
Moodys
Mallinckrodt
Boehringer Ingelheim
Federal Trade Commission

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 013401

« Back to Dashboard

NDA 013401 describes ALDOMET, which is a drug marketed by Merck and is included in three NDAs. Additional details are available on the ALDOMET profile page.

The generic ingredient in ALDOMET is methyldopa. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the methyldopa profile page.
Summary for 013401
Tradename:ALDOMET
Applicant:Merck
Ingredient:methyldopate hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Army
Baxter
QuintilesIMS
Johnson and Johnson
Cerilliant
UBS
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.